Search Within

Azeez Farooki

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (10)
  2. Division of Subspecialty Medicine (10)
  3. Endocrinology (10)
  4. Genitourinary Oncology Service (10)
  5. Solid Tumor Oncology Division (10)
  6. Survivorship Research (10)

More Groups

People
  1. Michael Morris (7)
  2. Aaron Mitchell (5)
  3. Akriti Mishra (3)
  4. Howard Scher (3)
  5. Sonia Persaud (3)
  6. Allison Lipitz Snyderman (2)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
  4. 2020 (2)
  5. 2017 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Internal Medicine (1)
  3. Cancer (1)
  4. Clinical Genitourinary Cancer (1)
  5. JCO Oncology Practice (1)
  6. Prostate (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American College of Physicians (1)
  3. Elsevier Inc. (1)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)
  6. Wiley Blackwell (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Costs to Medicare of nonrecommended bone-modifying agent use for castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Nemirovsky, D.; Mishra Meza, A.; Chakraborty, N.; Persaud, S.; Farooki, A.; Morris, M. J.
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer
    Journal Article

    Mitchell, A. P.; Persaud, S.; Palyca, P.; Salner, A.; Farooki, A.; Ostroff, J. S.; Morris, M. J.; Chimonas, S.
    Prostate (2024)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Barriers to guideline-concordant use of bone modifying agents for prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Persaud, S.; Chimonas, S.; Salner, A. L.; Palyca, P.; Farooki, A.; Ostroff, J. S.; Morris, M. J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Use of bone modifying agents for metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Farooki, A.; Panageas, K.; Bach, P. B.; Lipitz-Snyderman, A.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
    Journal Article

    McPherson, V.; Reardon, B.; Bhayankara, A.; Scott, S. N.; Boyd, M. E.; Whiting, K.; Garcia-Grossman, I. R.; Regazzi, A. M.; McCoy, A. S.; Kim, P. H.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Association of radical cystectomy and increased risk of skeletal-related events in bone-metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Easthausen, I. J.; Ghafoor, S.; Christos, P. J.; Donahue, T. F.; Rosenberg, J. E.; Farooki, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Maintaining bone health during hormonal therapy for prostate cancer
    Journal Article

    Farooki, A.; Scher, H. I.
    Annals of Internal Medicine (2017)

    Fulltext@MSK | Save
  • Severe hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: Risk factors and precautions for treating physicians
    Journal Article

    Autio, K. A.; Farooki, A.; Glezerman, I. G.; Chan, A.; Schneider, C. W.; Barr, H. C.; Seyboth, B. M.; Kampel, L. J.; Danila, D. C.; Rathkopf, D. E.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save